Patent · US Active

PCSK9 polypeptides

US7846706B2 · kind B2 · utility

19Cited by
2References
14Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 23, 2009
Grant dateDec 7, 2010
Priority date
Expiry dateJun 23, 2029

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY10T436/143333
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention provides novel polynucleotides encoding PCSK9b and PCSK9c polypeptides, fragments and homologues thereof. Also provided are vectors, host cells, antibodies, and recombinant and synthetic methods for producing said polypeptides. The invention further relates to diagnostic and therapeutic methods for applying these novel PCSK9b and PCSK9c polypeptides to the diagnosis, treatment, and/or prevention of various diseases and/or disorders related to these polypeptides. The invention further relates to screening methods for identifying agonists and antagonists of the polynucleotides and polypeptides of the present invention.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.